promising novel agents in aml: menin inhibitors
Published 3 months ago • 141 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
1:36
targeted therapy for aml
-
4:31
limitations of targeted therapy for aml
-
1:19
astx727 a molecularly-targeted agent as personalized maintenance therapy in patients with aml
-
2:46
targeted therapies available for the treatment of patients with aml
-
2:41
an overview of the latest advances in hematology
-
4:34
the genetics of acute myeloid leukemia (aml)
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
2:26
insights into the future of aml therapy: the increasing use of targeted agents
-
1:27
how do targeted treatments for idh1 and idh2 mutations work in acute myeloid leukemia (aml)?
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:33
the impact of novel targeted & immune therapies in leukemia
-
1:20
mimetics: the future of aml treatment?
-
3:50
antibody-based therapy in aml: immunotoxins and bites
-
2:11
the current role of immuno-oncology in aml and future outlooks
-
1:19
new treatments for aml
-
2:18
targeted vs. broader agents for maintenance in aml
-
2:18
future directions in aml: targeted therapies, antibody-radiation conjugates & new combinations
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
3:37
the future of aml treatment
-
2:25
clinical advances in acute myeloid leukemia
-
2:03
evaluating germline variant gfi1-36n and its impact on dna repair in aml